Yuyu Pharma, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported negative sales was KRW 0.00033 million compared to sales of KRW 0.00034 million a year ago. Net loss was KRW 7,180.9 million compared to KRW 5,987.68 million a year ago.

Basic loss per share from continuing operations was KRW 443 compared to KRW 378 a year ago. Basic loss per share was KRW 443 compared to KRW 378 a year ago.